Skip to main content
PolicySpeak
← All files
EBA

European Blood Alliance (EBA)

NGO · Belgium · EU Transparency Register 149855010621-40

6
positions filed
in the 665 files tracked
5
legislative files
of 665 tracked
3
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1106 non-governmental organisations on this site, they rank #255 by legislative files engaged, a count of participation, not a measure of influence.

1.1
declared lobbying FTE
self-declared
–
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2013
in the register since

Declares membership of

  • Common representation of Substances of Human Origin (SoHO)
  • https://europeanbloodalliance.eu/european-affairs/core-soho/
  • Alliance of Blood Operators (ABO: https://www.allianceofbloodoperators.org/)
  • Coalition of Blood for Africa (CoBA: https://cobaafrica.org/)
  • International Society of Blood Transfusion (ISBT: https://www.isbtweb.org/)
  • International Plasma and Fractionation Association (IPFA: https://ipfa.nl/)

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).

Register category
Non-governmental organisations
Registered as
European Blood Alliance (EBA)
Head office
Amsterdam, Netherlands
EU office
Brussels

Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track European in PolicySpeak: request access →

Follow European Blood Alliance (EBA)

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at European Blood Alliance (EBA)? so we know who speaks for it.

Their record over time

European Blood Alliance (EBA) filed 6 positions between 14 Dec 2020 and 30 Mar 2026, across 5 of the 665 legislative files tracked here, attaching a full position paper 3 times.

2020 · 1 filed2021 · 1 filed2022 · 2 filed2023 · 1 filed2026 · 1 filed

What they argued

Medicinal products for human usefiled 17 Oct 2023PDFsource

The European Blood Alliance, representing public/not-for-profit blood establishments, welcomes the European Commissions publication of its proposal for a reform of the EU pharmaceutical legislation. The review aims to reach a number of important goals, such as improving access to innovative medicines, promoting innovation in the sector and addressing shortages.

European Biotech Actfiled 30 Mar 2026PDFsource

The European Blood Alliance (EBA), representing public and non-profit blood establishments across Europe, welcomes the European Commissions proposal for a European Biotech Act. EBA wishes to remind EU and national policymakers that public and non-profit blood establishments are the original precursors of personalised medicine and have played an historic and central role in the development of many ground-breaking…

European Health Data Spacefiled 28 Jul 2022source

The European Blood Alliance (EBA) welcomes this proposal on the European Health Data Space (EHDS). European blood establishments represented by EBA have regularly asked for more and better data to increase donor protection and reinforce patient care; we believe that the EHDS can be a fundamental tool in working towards these goals.

Standards of quality and safety for substances of human origin intended for human applicationfiled 14 Dec 2020source

EBA agrees with the gaps and issues identified in the 1st part of the IIA and highlights the following: Reliance on 3rd countries on plasma for PDMPs is in part due to off-label non-evidence-based use.The EU needs to support more research on efficacy of the plasma-based products for a number of diseases while Member States (MS) need to increase their plasma collection from the not-for-profit sector EBA strongly…

European Medicines Agencyfiled 1 Feb 2021source

The European Blood Alliance (EBA, www.europeanbloodalliance.eu) welcomes the proposal for a European Medicines Agency (EMA) increased role in crises preparedness and management of Plasma-Derived Medicinal Products (PDMPs) supply.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put European Blood Alliance (EBA) next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.

Showing 5 of 117.

Is this your organization?

Everything on this page comes from European Blood Alliance (EBA)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.